@article{Vives2025,

title = {Text Messaging Versus Postal Reminders to Improve Participation in a Colorectal Cancer Screening Program: Randomized Controlled Trial},

author = {Nuria Vives and Gemma Binefa and Noemie Travier and Albert Farre and Jon Aritz Panera and Berta Casas and Carmen Vidal and Gemma Ibáñez-Sanz and Montse Garcia and },

doi = {10.2196/64243},

issn = {2291-5222},

year  = {2025},

date = {2025-01-01},

journal = {JMIR Mhealth Uhealth},

volume = {13},

publisher = {JMIR Publications Inc.},

abstract = {

            Background

            Mobile phone SMS text message reminders have shown moderate effects in improving participation rates in ongoing colorectal cancer screening programs.

          

          

            Objective

            This study aimed to assess the effectiveness of SMS text messages as a replacement for routine postal reminders in a fecal immunochemical test–based colorectal cancer screening program in Catalonia, Spain.

          

          

            Methods

            We conducted a randomized controlled trial among individuals aged 50 to 69 years who were invited to screening but had not completed their fecal immunochemical test within 6 weeks. The intervention group (n=12,167) received an SMS text message reminder, while the control group (n=12,221) followed the standard procedure of receiving a reminder letter. The primary outcome was participation within 18 weeks of the invitation. The trial was stopped early, and a recovery strategy was implemented for nonparticipants in the intervention group. We performed a final analysis to evaluate the impact of the recovery strategy on the main outcome of the trial. Participation was assessed using a logistic regression model adjusting for potential confounders (sex, age, and deprivation score index) globally and by screening behavior.

          

          

            Results

            The trial was discontinued early in September 2022 due to the results of the interim analysis. The interim analysis included 5570 individuals who had completed 18 weeks of follow-up (intention-to-treat). The SMS text message group had a participation rate of 17.2% (477/2781), whereas the control group had a participation rate of 21.9% (610/2789; odds ratio 0.71, 95% CI 0.62-0.82; P<.001). As a recovery strategy, 7591 (72.7%) out of 10,442 nonparticipants in the SMS text message group had an open screening episode and received a second reminder by letter, reaching a participation rate of 23% (1748/7591). The final analysis (N=24,388) showed a participation rate of 29.3% (3561/12,167) in the intervention group, which received 2 reminders, while the participation rate was 26.5% (3235/12,221) in the control group (odds ratio 1.16, 95% CI 1.09-1.23; P<.001).

          

          

            Conclusions

            Replacing SMS text messages with reminder letters did not increase the participation rate but also led to a decline in participation among nonparticipants 6 weeks after the invitation. However, sending a second reminder by letter significantly increased participation rates among nonparticipants within 6 weeks in the SMS text message group compared with those who received 1 postal reminder (control group). Additional research is essential to determine the best timing and frequency of reminders to boost participation without being intrusive in their choice of participation.

          

          

            Trial Registration

            ClinicalTrials.gov NCT04343950; https://www.clinicaltrials.gov/study/NCT04343950

          },

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{pmid39747650,

title = {The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis},

author = {Shah R and Hanna NM and Loo CE and David M and Mafra A and Fink H and McFerran E and Garcia M and Ghodssighassemabadi R and Acharya S and Niyibaga J and Langselius O and Frick C and Lasebikan N and Vignat J and Steinberg J and Hughes S and Kircher CE and Goldie CL and Egger S and Sullivan R and Ginsburg O and Bray F and Caruana M and Hui H and Ilbawi AM and Canfell K and Soerjomataram I},

doi = {10.1038/s43018-024-00880-4},

issn = {2662-1347},

year  = {2025},

date = {2025-01-01},

journal = {Nat Cancer},

volume = {6},

number = {1},

pages = {194--204},

abstract = {The coronavirus disease 2019 pandemic substantially impacted the delivery of cancer services and programs. Here we reviewed and synthesized the global scale and impact of pandemic-related delays and disruptions on cancer services, including diagnosis, diagnostic procedures, screening, treatment and supportive and palliative care. Based on data from 245 articles in 46 countries, we observed declines in the number of cancer screening participation (39.0%), diagnoses (23.0%), diagnostic procedures (24.0%) and treatment (28.0%), ranging from a 15.0% decline for radiotherapy to a 35.0% decline for systemic treatment during the pandemic compared to during the prepandemic period. Medium-human development index (HDI) category countries experienced greater reductions than high- and very-high-HDI countries. Missing data from low-HDI countries emphasize the need for increased investments in cancer surveillance and research in these settings. PROSPERO registration: CRD42022301816.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{pmid40520451,

title = {Role of medico-administrative database in the selection of the target population in colorectal cancer screening program},

author = {Koïvogui A and Benamouzig R and Balamou C and Binefa G and Hoeck S and Novak-Mlakar D and Duclos C},

doi = {10.1177/17562848251342340},

issn = {1756-283X},

year  = {2025},

date = {2025-01-01},

journal = {Therap Adv Gastroenterol},

volume = {18},

pages = {17562848251342340},

abstract = {BACKGROUND: Colorectal cancer (CRC) screening in average-risk populations requires filtering a target population based on medical information in population-based CRC screening programs (CRCSP). This study describes the level of consensus in medical exclusion practice and the role of the medico-administrative databases (MADB) in accurately targeting the eligible individuals for CRCSP screening campaigns.nnDESIGN: The descriptive study combined a cross-sectional survey and a non-systematic literature review.nnMETHODS: A cross-sectional survey was conducted among CRCSPs worldwide. Information was collected on the use of MADB for identifying consensus-based exclusion criteria (applied by >50% of CRCSPs). When a MADB was used, the study assessed whether the definition (code lists, medical terminologies) of the exclusion criteria was available. These definitions were compared between programs to evaluate the degree of consensus.nnRESULTS: In all, 20 out of the 31 CRCSPs (Australia, England, Manitoba, Ontario, Washington State, 26 European countries) participating in the survey implemented medical exclusions. Five consensus-based exclusion criteria were identified (personal history of CRC, inflammatory bowel disease, adenoma, recent colonoscopy, genetic risk). However, these criteria were not uniformly defined in MADBs (i.e., CRC phenotype includes ICD-10 codes C18-C21 in Catalonia, while the C21 code was excluded elsewhere). Furthermore, although the MADBs exist and contain relevant information, they remain inaccessible to screening management structures in some countries (e.g., in France).nnCONCLUSION: The number of consensus-based criteria was limited, and they were the least nuanced, likely because they are easier to collect using the current CRCSPs management resources. These consensual criteria can be queried in most MADBs. However, the use of MADBs was not standardized across programs for various reasons (absence of a database, unavailability of information in the database when it exists, inaccessibility of the database when it exists), limiting comparability between them. Standardizing the five consensus criteria across all programs would only be effective if the disparity caused by systemic failures in the organization of each program was controlled.},

keywords = {},

pubstate = {published},

tppubtype = {article}

}

@article{pmid40322742,

title = {The Evaluation of a Nursing Care Model for Breast Cancer: What Are Women's Priorities?},

author = {Rodriguez-Ortega A and Ferro T and Ochoa-Arnedo C and Campos G and Valverde Y and Medina JC and Borras JM},

doi = {10.1155/jonm/8653274},

issn = {1365-2834},

year  = {2025},

date = {2025-01-01},

journal = {J Nurs Manag},

volume = {2025},

pages = {8653274},

abstract = { To assess patient satisfaction with the breast care nurse (BCN) model and its adequacy in meeting patients' needs for information and support.  The BCN is a core multidisciplinary member of the breast cancer team. The evaluation of care models is necessary to detect gaps and improve the quality of care.  This cross-sectional descriptive study took place in a breast pathology unit and included patients with early breast cancer seen between 1 July 2016 and 30 June 2017 after finishing their treatment. Between July and December 2018, sociodemographic and clinical variables were collected from the clinical history, and satisfaction was measured using a questionnaire sent to the patients.  Of the 139 patients included, 99.3% reported that the BCN provided information correctly, 96.2% reported that she provided adequate information on self-care at home (96.2%), and 97.8% reported that the words of the BCN helped them feel better. However, some patients were unsure whether the BCN would have been willing to discuss alternative therapies (41%).  Patients were satisfied with the BCN, including her role in meeting information and support needs. However, some issues needed to be sufficiently addressed. Comprehensive, continuous assessment is required to understand patient needs. Training and specific studies on topics that are of interest to patients can help respond to these needs.  BCN functions are being developed in some countries. BCN results make it easier for healthcare managers to commit to this role and for nurses to develop all their competencies. BCN models must respond to international guidelines but are also determined by organizational resources. The evaluation of these models is essential and must be considered by users. Advanced practice nursing roles, including the BCN, are well established in some countries but developing in others. BCN results make it easier for healthcare managers to commit to this role and for nurses to develop all their skills. BCN models must respond to the elements determined by organizations that work to improve the quality of care for patients with breast cancer. However, they are also determined by organizational resources. The evaluation of these models is essential to correct deficiencies and improve the quality of care. An important part of the evaluation must take into account the user who receives the care, in terms of satisfaction and the form of patient-reported outcome measures (PROMs).},

keywords = {},

pubstate = {published},

tppubtype = {article}

}